{"name":"pH Pharma","slug":"ph-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"PHP-201 ophthalmic solution","genericName":"PHP-201 ophthalmic solution","slug":"php-201-ophthalmic-solution","indication":"Ocular surface disease (presumed, based on formulation type)","status":"phase_3"}]}],"pipeline":[{"name":"PHP-201 ophthalmic solution","genericName":"PHP-201 ophthalmic solution","slug":"php-201-ophthalmic-solution","phase":"phase_3","mechanism":"PHP-201 is an ophthalmic solution designed to treat ocular surface disease, likely through anti-inflammatory or lubricating mechanisms.","indications":["Ocular surface disease (presumed, based on formulation type)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxONjZVVUR2R2JGRUQ5Z3NvZ0FFLUNtQ2NHYnRCNk1qRHZYUGx3MFFwZkNaRTNZNm1qczBIOEVubkdwcjNUWDR6VlR5cnFud205d0NMSGZGcWdsYWpkRzBHdTRKT1NxNlZZNFNVN29CVHE4VVdxanBYMTFEcXNaaGVaODNMOXh2SElVWGxWRUxoV3F2YV8zTFlVeVc0MGwxQTdvZlBWLWNOcTkwdVBVaE5maTk0ODJSYUJtMURxQWJXVXlCdHYx?oc=5","date":"2026-03-30","type":"regulatory","source":"Fierce Pharma","summary":"United plots Tyvaso FDA filing after ph. 3 win elicits talk of 'new IPF standard' and blockbuster sales - Fierce Pharma","headline":"United plots Tyvaso FDA filing after ph. 3 win elicits talk of 'new IPF standard' and blockbuster sales","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPTHkydmNUdW9ENi1rX2FrVGVRSWZjNGlONlJvbkhBQ0ducFlZY0I0OGxtcFQ3U2c1SzZoQk9iMWRQUkhha3M2UE1EbF9WVUMxck9YWE1qbDFvX2tlZ1RWNF8tRklsX0p0MExyTXNpUEtodUNvdDY3NDRjRnpZVEpWRjlDV2JPY0Vq?oc=5","date":"2026-02-19","type":"patent","source":"Panay News","summary":"Generic meds seen taking 54% of PH pharma sales by 2030 - Panay News","headline":"Generic meds seen taking 54% of PH pharma sales by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxPTmNVbTRlVDdLNmd3RVp6Z3pxNGNVMW45Tk9TRER4aUU2RmpRVHpldnJkSnU0WW1Qc2VtLU9NUVgwcEk0alVmNDFGZVU2Y2hscFdUeWUwVExFV19fTEtZZm5VX1BnSEFOOFRTWFlHRHdYYjBGRFhXaGJpeThRY0Jrb2cwVG9La1dXM2JIcjV2dGtkclBmTW9lbHowRXNwTmIyTm44bFNuc1UyTW55ZGlGOHM0TXM?oc=5","date":"2026-01-23","type":"regulatory","source":"manilastandard.net","summary":"PH pharmaceutical group backs FDA ‘green lane’ for local medicine - manilastandard.net","headline":"PH pharmaceutical group backs FDA ‘green lane’ for local medicine","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQOXZIT3dSbkRxY3lrT1JybVd4TFNLSlBqUGR5akJKU3daVzk4N1pjR3dCT003UURnYl9VeWhmY19VZHRfVHJNTGhWTWl6UTR5cGpvdE9sdmZmUGJwRFNILXNmSUM1Q21JQjRHdWJqUXFLVnNOUWtMQmlQenhpd09ZSUtSUW40Z2FsYkJpZTRELVR4bzFVR2ZmM0laMDRUdW02emJVYkUxWUxMbFJPSVdXSmY1enZmbndjS0VjYw?oc=5","date":"2026-01-20","type":"regulatory","source":"Fierce Biotech","summary":"Tanabe Pharma's oral drug scores in ph. 3 rare disease study, though details remain in the dark - Fierce Biotech","headline":"Tanabe Pharma's oral drug scores in ph. 3 rare disease study, though details remain in the dark","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPV3hUX1ZpcF9XV0lwOWpacjI1UHgzZzhzS1M2MGZIV2djODFWWmEwcHBtQ3I0anJ0S0owREd2S1NVWGZ2a0pSQ3BINkRfYzd6T3YyWktDNEZsenFVNUQ2cEVXaWNBQkNlM0RYbXBKN2twZG54SVRlWjh5NGFUWjZXR3VuRHJEWGZJZEVBb1VTR1ZVdEdvVVlMSVQ2aXlCZF9aUDd3dWZUQQ?oc=5","date":"2026-01-16","type":"pipeline","source":"Fierce Pharma","summary":"After AbbVie and Genmab's ph. 3 survival miss for Epkinly in DLBCL, what's next? - Fierce Pharma","headline":"After AbbVie and Genmab's ph. 3 survival miss for Epkinly in DLBCL, what's next?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5ISFhTbF82Z01zZTY2cXJJc3NhN2NyY0MtQVh0M3gwb0JTd1FYMTFjalFWQUpIUnA0SlFXVEhYUDhWV2l6R3VfOTFJMDhTcHRBTWZkNUFIS2RITkRxc2J4aXJTNWN6dkUxdFZ5RTBn0gFyQVVfeXFMUG94TF8wenQ5T2ZydE5idE5LdHl3MUJPX0Z5QzVoNUdveTRLMEdpdDZvR1R3X2ZCRWZfODF2VVdXZFZFLUJLQ1hLSElpX2pSaENpSW05aDdoRkJyZEtMakNxeldVNTBRTkVDSFRTQ1JrU3pB?oc=5","date":"2025-11-03","type":"pipeline","source":"koreabiomed.com","summary":"Chong Kun Dang speeds up new drug development through external hires and internal reorganization - koreabiomed.com","headline":"Chong Kun Dang speeds up new drug development through external hires and internal reorganization","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxOREtYRXRuLWNmMm80YlU2UEtyM28tek1UaXVVdHlCemVEaEF5ckl3UmVCcGN1UVlrSlk1S210UVBZWjhsNVE2RHFBOG9iYVZZRG16M1RycDhmYmtBck9yT2xxWDhRaXNtZzNsLXRxRjRnQTZQdjZoSE0tSFNGQnlTc2ZLZU90VVJiVHVtVdIBkgFBVV95cUxPcjF6OXpfMnlJcG1tczEtVWtDU2g0emVaR1ZuNFBscDUzVmdvWGNUUndJM05QbEd0cU4tMGdqTWJGY1NmVU4xTGdOOGtUWUE4dDY4UHdfWEhVZTJHV1F5bFBaMEdpLW9xaUlDZF8zcmlCODJtQUZSR284dk9IeXlGQTFrelcwTlZWYXB3UFhIMDdJZw?oc=5","date":"2025-09-23","type":"earnings","source":"Inquirer.net","summary":"Philippine pharma sector revenues seen hitting $2B in 2025 - Inquirer.net","headline":"Philippine pharma sector revenues seen hitting $2B in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQV1Fxa2J3QXV5Z3djWlkzYkVZdTBJZks4cWRzdWhMU0lDMXRmdC1KNXJlTVo2SnBVWV9kRERTRmhObzVTbGFSSzRIM2FhSW9lQ0NDUlFhUktjTDhWN1RmV0VuVHpDTHkwZjZQVjVPRlQ1UTlRdzNlX3F6bmVnWFNsSlkwNnA2bkpvTGt4Yw?oc=5","date":"2025-09-23","type":"pipeline","source":"thephilbiznews","summary":"$2B growth potential seen in PH pharma roadmap - thephilbiznews","headline":"$2B growth potential seen in PH pharma roadmap","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQSWFyWkczbUVJeWloN2NiVHdqZkU3M3dCVlN5bXQzRHRlTjNXQjhPbUZSQ2F1R3Q2RllaSkEtN083empoRm9WRnFUdEJiWGhoYWphUUtYQm1PTjhZT3lVaG1QMUtjb1pvOFc4aUNWNDB3ZmhGSldGSzlhUERKQTZuTFBiOG10Y2fSAZQBQVVfeXFMT0tKc2p0eFJXTzJsTW4wbVFQMjQzRDZZUnFVSE5DZjZLRmVGWUp1WmhVR1JnTzZUSlBReTA2SnFhV1VKc0FGa0pyUFlJUU5ZUWt3UUZvdEd4WkFjUmpDYkYtdGFKalBPT05hdkIxZFpUNmdDZlZxSWNYNVpPX1ZLVGFNWVpKdWtOWDRxQ0dxQ0IzNVFZXw?oc=5","date":"2025-09-22","type":"pipeline","source":"SunStar Publishing Inc.","summary":"BOI pushes pharma roadmap at PCPI meet - SunStar Publishing Inc.","headline":"BOI pushes pharma roadmap at PCPI meet","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE0ySXJDaXlhSk5yYTFwOEFLNzFuVzQ0emVKZHlLbGdzZzJIRk1GeDQwWm5ONkVON1BUM0ljRFZkNWlHNzNrbm9FTzJjVmNYeWxO?oc=5","date":"2025-08-22","type":"pipeline","source":"Philippine News Agency","summary":"Report: PH pharma industry headed for 4.5% growth by 2029 - Philippine News Agency","headline":"Report: PH pharma industry headed for 4.5% growth by 2029","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQOU5wX1g3dnNkMFpqdlh1bEUyaEdoRW93UFFFUXlack1zMFlEWnZOb3oydG5GelBzSVpWVG1LYjJVQzNVVm5xYWMySXA0SVRvZ09UTmp1d3E5a2FpM3lhUTlvcGlxeHIydTJ6cWM3cTVwYnhkQ2VEQXY0ZUttbzRjbEZRYmVVdm4zSjAycEdRUHNraGw1WTVrUXltUlczdDQzRmxlcmViWlpvOHp4?oc=5","date":"2025-08-22","type":"pipeline","source":"InsiderPH","summary":"AstraZeneca, global giants help PH cement lead as Southeast Asia’s largest pharma market - InsiderPH","headline":"AstraZeneca, global giants help PH cement lead as Southeast Asia’s largest pharma market","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-21","type":"deal","source":"GMA Network","summary":"PEZA, AstraZeneca partner to boost pharma investments in PH - GMA Network","headline":"PEZA, AstraZeneca partner to boost pharma investments in PH","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}